scholarly journals Chronic Kidney Disease After Hematopoietic Cell Transplantation: A Systematic Review

2008 ◽  
Vol 8 (11) ◽  
pp. 2378-2390 ◽  
Author(s):  
M. J. Ellis ◽  
C. R. Parikh ◽  
J. K. Inrig ◽  
M. Kambay ◽  
U. D. Patel
Keyword(s):  
Systematic Review ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Cell Transplantation ◽  
Hematopoietic Cell Transplantation ◽  
Hematopoietic Cell

scholarly journals Chronic Kidney Disease Following Non-Myeloablative Hematopoietic Cell Transplantation

2006 ◽  
Vol 6 (1) ◽  
pp. 89-94 ◽  
Author(s):  
A. S. Weiss ◽  
B. M. Sandmaier ◽  
B. Storer ◽  
R. Storb ◽  
P. A. McSweeney ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Cell Transplantation ◽  
Hematopoietic Cell Transplantation ◽  
Hematopoietic Cell

Chronic Kidney Disease After Hematopoietic Cell Transplantation: Frequency, Risk Factors, and Outcomes

2009 ◽  
Vol 41 (7) ◽  
pp. 2895-2897 ◽  
Author(s):  
F. Saddadi ◽  
M. Hakemi ◽  
I. Najafi ◽  
K. Moghadam ◽  
A. Ghavamzadeh ◽  
...  
Keyword(s):  
Risk Factors ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Cell Transplantation ◽  
Hematopoietic Cell Transplantation ◽  
Hematopoietic Cell

scholarly journals Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation

Cancer ◽  
2008 ◽  
Vol 113 (7) ◽  
pp. 1580-1587 ◽  
Author(s):  
Michael Choi ◽  
Can-Lan Sun ◽  
Seira Kurian ◽  
Andrea Carter ◽  
Liton Francisco ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Cell Transplantation ◽  
Hematopoietic Cell Transplantation ◽  
Hematopoietic Cell ◽  
Long Term Survivors

scholarly journals HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis

2019 ◽  
Vol 3 (17) ◽  
pp. 2581-2585 ◽  
Author(s):  
Mohamad A. Meybodi ◽  
Wenhao Cao ◽  
Leo Luznik ◽  
Asad Bashey ◽  
Xu Zhang ◽  
...  
Keyword(s):  
Systematic Review ◽  
Cell Transplantation ◽  
Hematopoietic Cell Transplantation ◽  
Meta Analysis ◽  
Hematopoietic Cell ◽  
Free Survival ◽  
Relative Contribution ◽  
Haploidentical Hematopoietic Cell Transplantation ◽  
Matched Sibling ◽  
Outcome Differences

Abstract HLA haploidentical hematopoietic cell transplantation (haplo-HCT) using posttransplantation cyclophosphamide (PT-Cy) is an alternative strategy when a matched sibling donor (MSD) is not available. We performed a systematic review and meta-analysis to compare the outcomes of MSD vs haplo-HCT. Eleven studies (1410 haplo-HCT and 6396 MSD recipients) were meta-analyzed. All studies were retrospective and high quality, and 9 were multicenter. Haplo-HCT was associated with ~50% lower risk of chronic graft-versus-host disease (GVHD) (hazard ratio [HR], 0.55; 95% confidence interval [CI], 0.41-0.74), but higher risk of nonrelapse mortality (HR, 1.36; 95% CI, 1.12-1.66). Relapse, survival, acute GVHD, and GVHD-free relapse-free survival were not significantly different between the groups. Deciphering the relative contribution of PT-Cy and HLA disparity to the observed outcome differences between the groups requires further research.

Sign in / Sign up

Export Citation Format

Share Document